ResearcherUniversity of Tennessee Health Science CenterNo recent work listed

Kamalika Samanta

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6456-601X; OpenAlex author ID A5013401973. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2019: 1 paper

Papers 1

Gemcitabine Combination Nano Therapies for Pancreatic Cancer. Co-author DOI 10.3390/pharmaceutics11110574 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Meena Jaggi · 1 shared paper, 2019 · strength 0.11
- Paper Gemcitabine Combination Nano Therapies for Pancreatic Cancer. DOI 10.3390/pharmaceutics11110574 ↗
Murali Mohan Yallapu · 1 shared paper, 2019 · strength 0.11
- Paper Gemcitabine Combination Nano Therapies for Pancreatic Cancer. DOI 10.3390/pharmaceutics11110574 ↗
Sonam Kumari · 1 shared paper, 2019 · strength 0.11
- Paper Gemcitabine Combination Nano Therapies for Pancreatic Cancer. DOI 10.3390/pharmaceutics11110574 ↗
Saini Setua · 1 shared paper, 2019 · strength 0.11
- Paper Gemcitabine Combination Nano Therapies for Pancreatic Cancer. DOI 10.3390/pharmaceutics11110574 ↗
Subhash C. Chauhan · 1 shared paper, 2019 · strength 0.11
- Paper Gemcitabine Combination Nano Therapies for Pancreatic Cancer. DOI 10.3390/pharmaceutics11110574 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.